National Bank of Canada FI Buys 23,164 Shares of Outset Medical, Inc. (NASDAQ:OM)

National Bank of Canada FI lifted its stake in shares of Outset Medical, Inc. (NASDAQ:OM) by 79.2% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 52,407 shares of the company’s stock after purchasing an additional 23,164 shares during the quarter. National Bank of Canada FI’s holdings in Outset Medical were worth $35,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in the stock. Huntington National Bank boosted its holdings in Outset Medical by 46.2% in the 3rd quarter. Huntington National Bank now owns 63,306 shares of the company’s stock valued at $43,000 after purchasing an additional 20,000 shares during the period. Vanguard Personalized Indexing Management LLC purchased a new position in Outset Medical during the second quarter worth about $49,000. Ground Swell Capital LLC bought a new position in Outset Medical in the 2nd quarter worth about $49,000. Summit Securities Group LLC purchased a new stake in shares of Outset Medical in the 2nd quarter valued at about $105,000. Finally, Point72 Asia Singapore Pte. Ltd. bought a new stake in shares of Outset Medical during the 2nd quarter valued at about $259,000.

Outset Medical Stock Up 1.0 %

OM stock opened at $1.02 on Thursday. The company’s 50 day moving average is $0.81 and its 200 day moving average is $1.80. The stock has a market cap of $53.59 million, a price-to-earnings ratio of -0.37 and a beta of 2.16. The company has a current ratio of 6.49, a quick ratio of 5.04 and a debt-to-equity ratio of 4.12. Outset Medical, Inc. has a 1-year low of $0.44 and a 1-year high of $6.36.

Outset Medical Company Profile

Outset Medical, Inc, a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.